Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Prof
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office COP300
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 36. Taher K W, Johnson P N, Miller J L, Neely S, Gupta N. Efficacy and Safety of Prolonged Magnesium Sulfate Infusions in Children With Refractory Status Asthmaticus. Frontiers in pediatrics. 2022; 10 : 860921
37. Bobo K S, Cober M P, Eiland L S, Heigham M, King M, Johnson P N, Miller J L, Sierra C M. Correction to: Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022; 79 : 823
38. Johnson P N. ICU Psychosis and Delirium. American College of Clinical PHarmacy. 2022 : 101-124
39. Johnson P N, Drury A S, Gupta N. Continuous Magnesium Sulfate Infusions for Status Asthmaticus in Children: A Systematic Review. Frontiers in pediatrics. 2022; 10 : 853574
40. Besunder J B, Betters K A, Johnson P N, Srinivasan V, Stormorken A, Farrington E, Golianu B, Godshall A J, Acinelli L, Almgren C, Bailey C H, Boyd J M, Cisco M J, Damian M, deAlmeida M L, Fehr J, Fenton K E, Gilliland F, Howell J, Ruggles C A, Simone S, Su F, Sullivan J E, Tegtmeyer K, Traube C, Williams S, Berkenbosch J W. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2022; 23 : e74-e110
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 16. OU Health Sciences Center Student Government Association. Robert Magarian Faculty Award. Date: 2017.
17. American Association of Colleges of Pharmacy. Walmart Scholar Mentor (for Trisha Lepa). Date: 2016.
18. Pediatric Pharmacy Advocacy Group. Christensen Young Investigator Award (Served as resident mentor). Date: 2016.
19. Pediatric Pharmacy Advocacy Group. Fellow (FPPAG). Date: 2016.
20. Pediatric Pharmacy Advocacy Group. Scholarship in Teaching Award. Date: 2016.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results